Yale Jen
Stock Analyst at Laidlaw & Co.
(0)
# 5107
Out of 5,332 analysts
22
Total ratings
9.09%
Success rate
-42.51%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ICAD icad | Downgrades: Hold | n/a | n/a | n/a | 1 | Apr 17, 2025 | |
SLNO Soleno Therapeutics | Maintains: Strong Buy | 75 105 | 74.77 | 40.43% | 2 | Mar 27, 2025 | |
NVCT Nuvectis Pharma | Initiates Coverage On: Buy | 19 | 8.8 | 115.91% | 1 | Mar 17, 2025 | |
LFWD Lifeward | Initiates Coverage On: Buy | 10 | 1.35 | 640.74% | 1 | Feb 10, 2025 | |
ABVX Abivax | Initiates Coverage On: Buy | 48 | 6.76 | 610.06% | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 25 | 0.7 | 3471.43% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | 0.56 | 4364.29% | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | 0.16 | 4587.5% | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 0.8 | 1150% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 240 | 1.7 | 14017.65% | 1 | Sep 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 600 | n/a | n/a | 1 | Sep 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 32 | n/a | n/a | 1 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 720 | n/a | n/a | 1 | Sep 19, 2017 |